id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-Q-0427-0056,FDA,FDA-2004-Q-0427,"FDA/CFSAN Response to Fleminger, Inc. - Amendment",Other,AMD-Amendment,2011-05-02T04:00:00Z,2011,5,2011-05-02T04:00:00Z,,2013-07-27T23:50:27Z,,0,0,0900006480c2cbf0
FDA-2004-Q-0427-0055,FDA,FDA-2004-Q-0427,"""FDA Letter dated February 17, 2004 to Fleminger, Inc."" - [Dr. Lee's TeaForHealth (Fleminger, Inc.) - Supplement (5)] re: FDA-2004-Q-0427-0052",Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2010-07-15T04:00:00Z,2010,7,,,2010-07-15T17:34:22Z,,0,0,090000648047483a
FDA-2004-Q-0427-0053,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Petition for Reconsideration",Other,PRC-Petition for Reconsideration,2010-07-15T04:00:00Z,2010,7,2010-07-15T04:00:00Z,,2013-07-27T20:51:35Z,,0,0,090000648047483f
FDA-2004-Q-0427-0054,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-15T04:00:00Z,2010,7,2010-07-15T04:00:00Z,,2013-07-27T20:51:35Z,,0,0,0900006480474844
FDA-2004-Q-0427-0048,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-08-11T04:07:04Z,,0,0,0900006480474816
FDA-2004-Q-0427-0039,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-28T01:34:13Z,,0,0,0900006480474804
FDA-2004-Q-0427-0042,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-27T20:51:34Z,,0,0,090000648047480b
FDA-2004-Q-0427-0046,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-27T20:51:35Z,,0,0,0900006480474811
FDA-2004-Q-0427-0040,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-27T20:51:34Z,,0,0,0900006480474805
FDA-2004-Q-0427-0037,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Supplement (2)",Other,SUP-Supplement,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-27T20:51:34Z,,0,0,0900006480474802
FDA-2004-Q-0427-0047,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-08-11T04:07:04Z,,0,0,0900006480474813
FDA-2004-Q-0427-0049,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-27T20:51:35Z,,0,0,0900006480474817
FDA-2004-Q-0427-0038,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-27T20:51:34Z,,0,0,0900006480474803
FDA-2004-Q-0427-0043,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-28T01:34:13Z,,0,0,090000648047480d
FDA-2004-Q-0427-0050,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2010-07-14T23:37:35Z,,0,0,0900006480474832
FDA-2004-Q-0427-0051,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Supplement (4)",Other,SUP-Supplement,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2010-07-14T23:43:45Z,,0,0,0900006480474838
FDA-2004-Q-0427-0044,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-28T01:34:14Z,,0,0,090000648047480e
FDA-2004-Q-0427-0041,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-08-11T02:33:52Z,,0,0,090000648047480a
FDA-2004-Q-0427-0052,FDA,FDA-2004-Q-0427,"Dr. Lee's TeaForHealth (Fleminger, Inc.) - Supplement (5)",Other,SUP-Supplement,2010-07-14T04:00:00Z,2010,7,2010-07-14T04:00:00Z,,2013-07-27T20:51:35Z,,0,0,090000648047483c
FDA-2004-Q-0427-0036,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Qualified Health Claim Petition (3 of 3)",Other,QHC-Qualified Health Claims,2010-07-13T04:00:00Z,2010,7,2010-07-13T04:00:00Z,,2013-07-27T20:51:33Z,,0,0,090000648047474d
FDA-2004-Q-0427-0035,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Qualified Health Claim Petition (2 of 3)",Other,QHC-Qualified Health Claims,2010-07-13T04:00:00Z,2010,7,2010-07-13T04:00:00Z,,2013-07-27T20:51:33Z,,0,0,090000648047473f
FDA-2004-Q-0427-0034,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Qualified Health Claim Petition",Other,QHC-Qualified Health Claims,2010-06-22T04:00:00Z,2010,6,2010-06-22T04:00:00Z,,2010-10-29T01:09:53Z,,0,0,090000648047473e
FDA-2004-Q-0427-0033,FDA,FDA-2004-Q-0427,"Fleminger, Inc. - Letter",Other,LET-Letter,2008-09-16T04:00:00Z,2008,9,2008-09-16T04:00:00Z,,2013-08-11T04:28:10Z,,0,0,090000648070093b
FDA-2004-Q-0427-0032,FDA,FDA-2004-Q-0427,"FDA Response to Fleminger, Inc. - Petition Denial (2)",Other,PDN-Petition Denial,2008-09-16T04:00:00Z,2008,9,2008-09-16T04:00:00Z,,2010-07-09T14:47:04Z,,0,0,0900006480700904
FDA-2004-Q-0427-0031,FDA,FDA-2004-Q-0427,"FDA Repsonse to Fleminger, Inc. - Letter",Other,LET-Letter,2005-09-21T04:00:00Z,2005,9,,,2010-07-09T14:54:37Z,,0,0,0900006480474843
FDA-2004-Q-0427-0011,FDA,FDA-2004-Q-0427,"Tab 48 - ""Comparative Validation of the Block, Willett, and National Cancer Institute Food Frequency Questionnaires: The Eating at America's Table Study"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T20:00:40Z,,0,0,090000648047481c
FDA-2004-Q-0427-0026,FDA,FDA-2004-Q-0427,"Tab 1 - ""Systems to Rate the Strength of Scientific Evidence"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T18:39:46Z,,0,0,090000648047482b
FDA-2004-Q-0427-0027,FDA,FDA-2004-Q-0427,"FDA/CFSAN Response Letter to Fleminger, Inc. - Petition Denial",Other,PDN-Petition Denial,2005-07-07T04:00:00Z,2005,7,,,2010-07-08T18:28:14Z,,0,0,090000648047482c
FDA-2004-Q-0427-0010,FDA,FDA-2004-Q-0427,"Tab 49 - ""Green Tea and the Risk of Breast Cancer: Pooled Analysis of Two Prospective Studies in Japan"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T20:04:17Z,,0,0,090000648047481b
FDA-2004-Q-0427-0020,FDA,FDA-2004-Q-0427,"Tab 15 - ""Gastric Cancer"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:13:43Z,,0,0,0900006480474825
FDA-2004-Q-0427-0009,FDA,FDA-2004-Q-0427,"Tab 50 - ""Epidemiology: Beyond the Basics"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T20:08:22Z,,0,0,090000648047481a
FDA-2004-Q-0427-0016,FDA,FDA-2004-Q-0427,"Tab 29 - ""Diet, Nutrition and the Prevention of Cancer"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:34:23Z,,0,0,0900006480474821
FDA-2004-Q-0427-0024,FDA,FDA-2004-Q-0427,"Tab 5 - ""Reference Manual on Scientific Evidence"" - [Fleminger, Inc. – Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T18:58:26Z,,0,0,0900006480474829
FDA-2004-Q-0427-0018,FDA,FDA-2004-Q-0427,"Tab 24 - ""Categories of Scientific Evidence--In Vitro Data"" - [Fleminger, Inc. – Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:22:56Z,,0,0,0900006480474823
FDA-2004-Q-0427-0008,FDA,FDA-2004-Q-0427,"Tab 50 - ""Epidemiology: Beyond the Basics - 'Chapter 4: Understanding Lack of Validity: Bias'"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T20:11:17Z,,0,0,0900006480474819
FDA-2004-Q-0427-0017,FDA,FDA-2004-Q-0427,"Tab 25 - ""Protective Effect of Green Tea Against Prostate Cancer: A Case-Control Study in Southeast China"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:31:07Z,,0,0,0900006480474822
FDA-2004-Q-0427-0019,FDA,FDA-2004-Q-0427,"Tab 23 - ""Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:18:54Z,,0,0,0900006480474824
FDA-2004-Q-0427-0015,FDA,FDA-2004-Q-0427,"Tab 43 - ""Gastric Cancer (PDQ®): Prevention; Health Professional Version"" -  [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:44:59Z,,0,0,0900006480474820
FDA-2004-Q-0427-0023,FDA,FDA-2004-Q-0427,"Tab 6 - ""Food Labeling: Health Claims; Plant Sterol/Stanol Esters and Coronary Heart Disease"" - [Fleminger, Inc. – Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:03:20Z,,0,0,0900006480474828
FDA-2004-Q-0427-0013,FDA,FDA-2004-Q-0427,"Tab 46 - ""A Case-Control Study of Diet and Prostate Cancer in Japan: Possible Protective Effect of Traditional Japanese Diet"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:52:02Z,,0,0,090000648047481e
FDA-2004-Q-0427-0014,FDA,FDA-2004-Q-0427,"Tab 44 - Interpreting Precursor Studies: What Polyp Trials Tell Us About Large-Bowel Cancer"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:49:09Z,,0,0,090000648047481f
FDA-2004-Q-0427-0007,FDA,FDA-2004-Q-0427,"List of Contents - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Other,PDN-Petition Denial,2005-07-07T04:00:00Z,2005,7,,,2010-07-08T18:34:52Z,,0,0,0900006480474818
FDA-2004-Q-0427-0028,FDA,FDA-2004-Q-0427,"Tab 54 - ""USDA Nutrient Database for Standard Reference, Release 17"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T20:14:18Z,,0,0,090000648047482d
FDA-2004-Q-0427-0029,FDA,FDA-2004-Q-0427,"Tab 58 - ""An Introduction to Scientific Research"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T20:16:12Z,,0,0,090000648047482e
FDA-2004-Q-0427-0030,FDA,FDA-2004-Q-0427,"Tab 2 - ""Cancer Facts & Figures 2004"" - [Fleminger, Inc. – Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T18:52:28Z,,0,0,090000648047482f
FDA-2004-Q-0427-0012,FDA,FDA-2004-Q-0427,"Tab 47 - ""Guide to Clinical Trials"" - [Fleminger, Inc. - Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:55:32Z,,0,0,090000648047481d
FDA-2004-Q-0427-0021,FDA,FDA-2004-Q-0427,"Tab 13 - ""The Environment and Disease: Association or Causation?"" - [Fleminger, Inc. – Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:09:24Z,,0,0,0900006480474826
FDA-2004-Q-0427-0025,FDA,FDA-2004-Q-0427,"Tab 3 - ""Development, Validation and Utilisation of Food-Frequency Questionnaires - A Review"" - [Fleminger, Inc. – Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T18:55:42Z,,0,0,090000648047482a
FDA-2004-Q-0427-0022,FDA,FDA-2004-Q-0427,"Tab 11 - ""Molecular Biology and Epidemiology of Cancer"" - [Fleminger, Inc. – Petition Denial] re: FDA-2004-Q-0427-0027",Supporting & Related Material,PDN-Petition Denial(Supporting and Related Material),2005-07-07T04:00:00Z,2005,7,,,2010-07-08T19:06:51Z,,0,0,0900006480474827
FDA-2004-Q-0427-0045,FDA,FDA-2004-Q-0427,Milford Hospital - Letter,Other,LET-Letter,2005-06-17T04:00:00Z,2005,6,,,2013-07-27T20:51:35Z,,0,0,0900006480474810
FDA-2004-Q-0427-0006,FDA,FDA-2004-Q-0427,"FDA/CFSAN Memorandum to Fleminger, Inc.",Other,M-Memorandum,2005-06-14T04:00:00Z,2005,6,,,2013-08-11T04:07:04Z,,0,0,0900006480474809
FDA-2004-Q-0427-0005,FDA,FDA-2004-Q-0427,"FDA Response to Fleminger, Inc. - Letter",Other,LET-Letter,2005-02-17T05:00:00Z,2005,2,,,2013-07-27T20:51:34Z,,0,0,0900006480474808
FDA-2004-Q-0427-0003,FDA,FDA-2004-Q-0427,"FDA Response to Fleminger, Inc - Letter",Other,ANS-Answer,2004-12-06T05:00:00Z,2004,12,,,2013-07-27T20:51:34Z,,0,0,0900006480474806
FDA-2004-Q-0427-0004,FDA,FDA-2004-Q-0427,FDA Response to Mr. and Mrs. Richard James - Comment,Other,,2004-12-06T00:00:00Z,2004,12,,,2013-08-11T04:07:04Z,,0,1,0900006480474807
FDA-2004-Q-0427-0002,FDA,FDA-2004-Q-0427,"FDA Response to Fleminger, Inc. - Letter",Other,LET-Letter,2004-04-09T04:00:00Z,2004,4,,,2013-07-27T20:51:34Z,,0,0,0900006480474800
FDA-2004-Q-0427-0001,FDA,FDA-2004-Q-0427,"Acknowledgement Letter to Fleminger, Inc.",Other,ACK-Acknowledgement Letter,2004-03-18T05:00:00Z,2004,3,,,2010-07-09T19:27:47Z,,0,0,090000648047470d